Trade Beam Therapeutics Inc. - BEAM CFD

Trading Conditions

• Type: CFD
• Spread: 0.13
• Long position overnight funding adjustment: -0.02171%
• Short position overnight funding adjustment: -0.00052%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 25.42
• Open: 25.25
• 1-Year Change: 4.6%
• Day's Range: 25.25 - 25.89

What is Beam Therapeutics Inc. (BEAM)?

Beam Therapeutics Inc. is a biotechnology company focused on developing precision genetic medicines through base editing technology. The company aims to create therapies that can precisely edit single nucleotides within DNA to correct genetic mutations associated with various diseases. Beam Therapeutics' platform leverages base editing, a form of genome editing that enables targeted and efficient modification of genetic sequences without causing double-stranded DNA breaks. Its research pipeline includes programs targeting rare genetic disorders, oncology, and other therapeutic areas. The company collaborates with academic institutions and industry partners to advance its technology and therapeutic candidates. Beam Therapeutics operates in the broader field of gene editing, contributing to the development of next-generation treatments that seek to address the underlying causes of genetic diseases. Its approach emphasizes specificity and reduced off-target effects compared to earlier gene editing methods.

Beam Therapeutics Inc. Stock Price Today: Live Overview

The price today is shaped by ongoing market movements, as Beam Therapeutics Inc trades at $25.90. It has seen price action between $25.2 and $25.92, marking a daily shift of +1.2579%.

FAQ: Beam Therapeutics Inc. (BEAM)

What is the current price of BEAM stock?

The last recorded price is $25.90.

Does BEAM pay dividends?

The company does not pay dividends.

Does BEAM have a formal corporate presence or regional headquarters in the UAE?

Beam Therapeutics Inc. does not have a registered presence or office in the UAE and operates through partners or distributors only.

What is BEAM best known for?

Beam Therapeutics Inc. is most famous for its development of precision genetic medicines using base editing technology.

What assets are typically shown together with BEAM?

Commonly shown alongside BEAM: 2x Long VIX Futures ETF, Catalyst Pharmaceuticals, Magnachip Semiconductor Corp